Last edition
News about "American Society of Hematology "
AstraZeneca Unveils Broadest Haematology Data Set Yet at ASH 2025
AstraZeneca is advancing its ambition to transform haematology care with new data from its expanding pipeline and portfolio at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, taking place from 6–9 December 2025.
American Society Of Hematology | 05/12/2025 | By Darshana | 378
GSK Showcases New Advances in Blood Cancer Treatments
GSK plc will present new data from its haematology portfolio at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, reinforcing the potential of its therapies to redefine outcomes for patients with difficult-to-treat blood cancers.
American Society Of Hematology | 03/12/2025 | By Darshana | 148
Syndax Announces Positive Revuforj Data in Acute Leukemias from Multiple Trials
Revuforj is the company's oral, first-in-class menin inhibitor that is FDA approved for the treatment of relapsed or refractory (R/R) acute leukemia with a lysine methyltransferase 2A gene (KMT2A) translocation in adult and pediatric patients one year and older.
American Society Of Hematology | 09/12/2024 | By Aishwarya | 466
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy